Invenire Partners, LP Inotiv, Inc. Transaction History
Invenire Partners, LP
- $65.3 Million
- Q3 2022
A detailed history of Invenire Partners, LP transactions in Inotiv, Inc. stock. As of the latest transaction made, Invenire Partners, LP holds 95,000 shares of NOTV stock, worth $152,950. This represents 100.0% of its overall portfolio holdings.
Number of Shares
95,000Holding current value
$152,950% of portfolio
100.0%Shares
1 transactions
Others Institutions Holding NOTV
# of Institutions
91Shares Held
6.73MCall Options Held
154KPut Options Held
57.7K-
Vanguard Group Inc Valley Forge, PA1.04MShares$1.68 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny484KShares$778,9110.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN449KShares$723,1450.0% of portfolio
-
Kpp Advisory Services LLC Louisville, KY228KShares$366,7430.68% of portfolio
-
Goldman Sachs Group Inc New York, NY224KShares$360,2050.0% of portfolio
About Inotiv, Inc.
- Ticker NOTV
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 25,594,500
- Market Cap $41.2M
- Description
- Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segme...